FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
Quiz|Articles|February 7, 2024
Influenza Vaccines: 4 Questions on What to Order, Which to Use
Author(s)Terry Brenneman, MD
Influenza continues to rage in some parts of the US; try these 4 quick questions on vaccines you may or may not have on hand.
Advertisement
Pre-orders for the following year's flu vaccine usually start in January and need to be completed by sometime in March. Let's take a look back at the season in progress and see what you know about the 2023-2024 vaccines.
Question 1. How many quadrivalent influenza vaccines were FDA-licensed for use in the US as of December 2023?
Advertisement
Related to this article
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.
Pre-existing antibodies to common microbes predicted COVID-19 vaccine response strength in healthy and immunosuppressed adults.
The organizations challenge a presidential executive order narrowing routine childhood vaccine recommendations and urging vaccines to be given separately.
FDA acceptance starts review of clesrovimab for second-season RSV prevention in high-risk children younger than 2 years.
Endocrine Society statement highlights key research gaps on obesity drugs—who benefits, long-term dosing, safety, and measuring success beyond weight loss.
Advertisement
Advertisement
Trending on Patient Care Online
1
ASH Raises Ferritin Thresholds for Diagnosing Iron Deficiency
2
FDA Approves Finerenone for CKD Associated With Type 1 Diabetes
3
Combating Prostate Cancer Misconceptions in Primary Care: An Expert Discussion
4
Sentinel Antibodies May Identify Patients With Blunted Vaccine Responses
5